|
2014
|
Invention
|
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzami... |
|
|
Invention
|
Metabolites of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1... |
|
|
Invention
|
Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors.
The present invention ... |
|
|
Invention
|
Modulators of indoleamine 2,3-dioxygenase and methods of using the same.
The present invention i... |
|
|
Invention
|
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase. The present invention is directed... |
|
|
Invention
|
Heteroaryl substituted pyrrolo[2,3-b] pyridines and pyrrolo[2,3-b] pyrimidines as janus kinase in... |
|
|
Invention
|
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3... |
|
|
Invention
|
Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d] pyrimidin-4-yl)-1h-pyrazol-1-yl)-... |
|
|
Invention
|
Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-5-yl-amines as janus kinase inhibit... |
|
|
Invention
|
Processes and intermediates for making a jak inhibitor. This invention relates to processes and i... |
|
|
Invention
|
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors. The present in... |
|
|
Invention
|
Piperazinylpiperidine derivatives as chemokine receptor antagonists. The present invention relate... |
|
2013
|
Invention
|
Azepine inhibitors of janus kinases. The present invention provides compounds that modulate the a... |
|
|
Invention
|
Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhi... |
|
|
Invention
|
Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-... |
|
|
Invention
|
Imidazotriazines and imidazopyrimidines as kinase inhibitors.
The present invention is directed ... |
|
|
Invention
|
Azetidine and cyclobutane derivatives as jak inhibitors.
The present invention relates to azetid... |
|
|
Invention
|
Substituted heterocycles as janus kinase inhibitors. The present invention provides substituted t... |
|
|
Invention
|
Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamid... |
|
|
Invention
|
N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase. The present invention ... |
|
|
Invention
|
Processes for preparing jak inhibitors and related intermediate compounds. The present invention ... |
|
|
Invention
|
Modulators of indoleamine 2,3-dioxygenase and methods of using the same. The present invention is... |
|
2012
|
Invention
|
3-aminopyrrolidine derivatives as modulators of chemokine receptors. The present invention relate... |
|
|
Invention
|
Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors. The present invention provides... |
|
|
Invention
|
Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1. The present invention... |
|
|
Invention
|
Janus kinase inhibitors for treatment of dry eye and other eye related diseases.
Methods, kits, ... |
|
|
Invention
|
Lactam compounds and their use as pharmaceuticals. The present invention relates to inhibitors of... |
|
2011
|
Invention
|
Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3. The present invention r... |
|
|
Invention
|
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors. The present invention provi... |
|
|
Invention
|
Azetidine and cyclobutane derivatives as jak inhibitors. The present invention relates to azetidi... |
|
|
Invention
|
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors. The p... |
|
|
Invention
|
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors. The present i... |
|
|
Invention
|
N-substituted piperidines and their use as pharmaceuticals. The present invention relates to inhi... |
|
|
Invention
|
Modulators of indoleamine 2,3-dioxygenase and methods of using the same for treating cancer. The ... |
|
|
Invention
|
Fused pyrrole derivatives as pi3k inhibitors. The present invention provides fused pyrrole deriva... |
|
|
Invention
|
Topical formulation for a jak inhibitor.
This invention relates to pharmaceutical formulations f... |
|
|
Invention
|
Piperidin-4-yl azetidine derivatives as jak1 inhibitors. The present invention provides piperidin... |
